An interesting article in Forbes on GDF11, anti-aging drugs and companies:
For an example of how hard it is to develop an anti-aging medicine, check this out. It’s some of the coolest and creepiest science to have been published in major academic journals. But is it ready to form the basis of a pharmaceutical company?
Read more
Comments are closed.